Brian Kelly

Celtic Catalysts was an innovative venture capital backed company that has developed ground-breaking chemistry that enables its clients in the pharmaceutical, biotech and fine chemicals industries to realize significant manufacturing cost savings. The company has a strong and energetic management and scientific team who are focused on providing its customers and collaborators with products and services of the highest caliber. Its chemists have a broad spectrum of experience in production, process development, medicinal chemistry, asymmetric catalysis, organometallics and general chemistry. All of its research chemists hold doctorates, and many have postdoctoral experience gained in well-known laboratories and companies. The areas of chemistry in which it works can broadly speaking be considered to fall into the following categories: Unnatural amino acid synthesis, Asymmetric catalysis, Phosphorus chemistry, particularly generating P-chirality, Enantioselective synthesis, Medicinal chemistry route development and process optimization, and Chiral HPLC method development and preparative HPLC. It has the abilities and facilities to work from milligram to multi-kilo scale (and multi ton scale in collaboration with manufacturing partners) and it has onsite access to the full spectrum of analytical tools-NMR, MS, GC, HPLC and X-ray crystallography.